Back to search
FDAFDA · Food and drugs·Recall number D-0650-2016

Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21

Published February 10, 2016 · Recall initiated: January 28, 2016

Summary

FDA records drug Class III recall D-0650-2016, published February 10, 2016 and initiated January 28, 2016. Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Status: Terminated; Reported quantity: 868 unit cartons (86,800 tablets); Lot: Lot # 3063759, Exp.07/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Distributor
Nationwide
Lot
Lot # 3063759, Exp.07/16
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21 recalled?

Yes. FDA published recall D-0650-2016 on February 10, 2016. Reported hazard: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter